{"id":"matched-transdermal-placebo-gel","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2109015","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a placebo comparator product formulated as a transdermal gel to match an active pharmaceutical agent in a clinical trial setting. It contains no active pharmaceutical ingredient and is used to provide blinding and control in randomized controlled trials conducted by Manchester University NHS Foundation Trust. The matched formulation ensures that trial participants and investigators cannot distinguish the placebo from the active treatment based on sensory characteristics.","oneSentence":"A matched placebo formulation designed to mimic the appearance, texture, and application method of an active transdermal gel for use as a control in clinical trials.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:53:55.421Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04977986","phase":"PHASE3","title":"Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome","status":"COMPLETED","sponsor":"Zynerba Pharmaceuticals, Inc.","startDate":"2021-09-13","conditions":"Fragile X Syndrome","enrollment":215},{"nctId":"NCT03614663","phase":"PHASE2, PHASE3","title":"Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)","status":"COMPLETED","sponsor":"Zynerba Pharmaceuticals, Inc.","startDate":"2018-06-12","conditions":"Fragile X Syndrome","enrollment":212},{"nctId":"NCT00190060","phase":"PHASE4","title":"Study of The Effects of Testosterone in Frail Elderly Men","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2004-10","conditions":"Frailty, Sarcopenia","enrollment":262}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Matched transdermal placebo gel","genericName":"Matched transdermal placebo gel","companyName":"Manchester University NHS Foundation Trust","companyId":"manchester-university-nhs-foundation-trust","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}